Click to view our accessibility statement Delivering on HopeTM ABOUT US PATIENTS & FAMILIES PRODUCTS PIPELINE CAREERS INVESTORS Contact Us About Neurocrine OUR COMPANY Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie) NEUROCRINE BIOSCIENCES CORPORATE INFORMATION The Company’s common stock is traded on the Nasdaq Global Select Market System under the symbol “NBIX” Contact Information Investor Relations ir@neurocrine.com Telephone: (858) 617-7600 Neurocrine Biosciences 12780 El Camino Real San Diego, CA 92130 Telephone: (858) 617-7600 Fax: (858) 617-7602 ABOUT US About Neurocrine Leadership Team Culture & Values Diversity, Equity & Inclusion News & Events Webcasts & Presentations Contact Us ©2021 Neurocrine Biosciences, Inc. All Rights Reserved. Privacy Policy Cookie Policy Terms & Conditions Accessibility Sitemap